What is Rythm?
Rythm is a pioneering neurotechnology company dedicated to transforming the understanding of the human brain to improve health and well-being. The company's expertise spans sleep medicine, neuroscience, engineering, machine learning, and advanced computing, bringing together a world-class team. Rythm's initial product, Dreem, an active wearable device designed to enhance sleep quality, was first introduced through a limited series program in 2016. Operating from Paris and San Francisco, Rythm fosters close collaborations with leading research institutions and hospitals to advance neuroscience research and development.
How much funding has Rythm raised?
Rythm has raised a total of $11M across 1 funding round:
Unspecified
$11M
Unspecified (2016): $11M, investors not publicly disclosed
What's next for Rythm?
The substantial enterprise-level funding and recent strategic investment position Rythm for accelerated growth and further innovation in the neurotechnology space. This capital infusion is expected to fuel the expansion of its research initiatives, enhance its product development pipeline, and potentially broaden its market reach. Rythm's commitment to collaborating with top-tier research bodies suggests a continued focus on evidence-based advancements and the translation of scientific discoveries into tangible health solutions. The company's trajectory indicates a strong potential for significant impact in improving sleep quality and overall brain health.
See full Rythm company page
